Literature DB >> 1145435

Development of two indices of postoperative morbidity.

W D Owens, M H Dykes, J P Gilbert, B McPeek, M B Ettling.   

Abstract

Two indices of postoperative morbidity, Nursing Assessment Index and Observed Treatment Index, are described and evaluated in this study of 4,182 consecutive anesthetics. The use of these indices in studies of the quality and effectiveness of surgical and anesthetic care should increase the economy and precision with which the causes of unsatisfactory outcome are identified. Specific illustrations of the relationship of the preanesthetic status of patients to their postoperative morbidity as measured by these indices and mortality rates are given. In addition these two indices of morbidity measured on the seventh postoperative day are shown to be strongly co-related with subsequent in-hospital deaths. Thus, of the 100 patients with a Nursing Assessment Index worse than 3, 19 percent died; only 0.4 percent of the 550 patients who had no morbidity as measured by this index died. Although they ultimately survive, about an equal number of patients become seriously ill as die follow operations.

Entities:  

Mesh:

Year:  1975        PMID: 1145435

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

Review 1.  [Biomedical and clinimetric approaches in determining the causes of perioperative risk: developing a German ASA classification].

Authors:  W Lorenz; W Dick; T Junginger; C Ohmann; A Doenicke; M Rothmund
Journal:  Langenbecks Arch Chir       Date:  1987

2.  ASA Physical Status and age predict morbidity after three surgical procedures.

Authors:  D J Cullen; G Apolone; S Greenfield; E Guadagnoli; P Cleary
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

3.  Enhanced recovery program in total hip arthroplasty.

Authors:  Amitabh J Dwyer; Payam Tarassoli; William Thomas; Paul Porter
Journal:  Indian J Orthop       Date:  2012-07       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.